Michail Nomikos

Assistant Professor of Biochemistry

Qatar University

Dr. Nomikos earned his B.Sc. with Honours in Biochemistry from the University of Liverpool (UK) in 2000; and his M.Sc. in Medical Genetics with Immunology from Brunel University (London, UK) in 2002. The same year, he was awarded a PhD studentship from the College of Medicine at Cardiff University (UK) to perform his Ph.D studies. After completing his Ph.D, he joined the National Center for Scientific Research ‘Demokritos’ in Athens (Greece) as a Post-Doctoral Research Fellow. In 2012, he returned to Cardiff University as a Senior Research Associate. In 2014, Dr. Nomikos was awarded a highly competitive Intra-European (IEF) Marie Curie Fellowship from the European Commission to perform his research at the College of Medicine (Cardiff University) until 2016. In September 2016, he joined Qatar University as an Assistant Professor of Biochemistry, at the College of Medicine. His research focuses on understanding the process of cytoplasmic calcium signaling in different cell types, including egg activation during mammalian fertilization. Moreover, his research interests involve the elucidation of the molecular mechanism(s) by which mutations in calmodulin or Ryanodine Receptor 2 genes lead to cardiac arrhythmias and early onset sudden cardiac death. Through his lifetime interest in reproductive biology, he has developed a distinct research theme. Dr. Nomikos has a strong publication record, including over 35 publications (and two book chapters) in international peer-reviewed, high impact factor scientific journals. Dr. Nomikos’ leading role has been maintained and evidenced by his first and corresponding authorship on a series of important, high-impact papers. Moreover, he has also contributed novel ideas to the reproductive biology field by publishing several authoritative reviews on the calcium signaling via PLC during mammalian fertilization. In 2013, Dr. Nomikos was awarded the prestigious ‘Fertility and Sterility Investigator Achievement Award’ at the annual meeting of the American Society for Reproductive Medicine (ASRM).